Background In November 2017, the Food and Drug Administration (FDA) approved a version of a second-generation antipsychotic, aripiprazole, embedded with a sensor (Abilify MyCite). Objective To ...

However, the use of aripiprazole in treating auditory abnormal sensations—particularly in cases without frank psychosis—has not been well documented. Given the overlapping pathophysiology between ...

Alkermes plc (Nasdaq: ALKS) today announced the presentation of accepted research at key scientific conferences this spring, including presentations largely related to its psychiatry products ...